GT Biopharma Inc (GTBP): GTBP is one of 3 Biotech Stocks See Heal...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

GT Biopharma Inc (GTBP)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	662
Boards Moderated	0
Alias Born	07/12/2018

Re: None

Monday, 08/13/2018 8:12:28 AM

Monday, August 13, 2018 8:12:28 AM

GTBP is one of 3 Biotech Stocks See Healthy Progress This Month

GT Biopharma (GTBP) – Market Cap: $96,832,678

This small cap biotech company has put together a vast pipeline of treatments. Its more recent highlights center around the company’s immuno-oncology platforms. Aside from announcing a private placement of convertible debentures for gross proceeds of $5,140,000, GT Biopharma has also begun to build relationship to enhance its OXS-1550.

The company announced on July 19 a Material Transfer Agreement between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center, University of Minnesota.

This Major Pharmaceutical Company will supply a formulation of their multibillion-dollar, widely prescribed oncology drug, which has been approved for use in several hematologic malignancies to Dr. Vallera to be used in this study.

https://biotechinvesting.finance.blog/2018/08/09/3-biotech-stocks-see-healthy-progress-this-month/

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent GTBP News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:46:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 05:15:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 08:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:00:11 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2023 10:25:12 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2023 10:23:32 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/06/2023 10:21:33 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 01:00:37 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 09:23:48 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 09/19/2023 03:56:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2023 08:55:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:29:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:26:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 01:00:11 PM

More GTBP News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow